Articles

For founders and CEOs in the life sciences sector, few decisions are as consequential as selling your company. Whether the goal is...

The ink is dry. The press release is out. Everyone’s congratulating each other. Yes, it truly is a great day. But now comes the part that...

Sellers don’t get paid for what they know. They get paid for what the buyer understands. And in carve-outs, few sellers make it easy.  ...

As carve-out activity accelerates in 2025, dealmakers are navigating an increasingly complex landscape. Corporates continue to divest...

In today’s M&A landscape, signing the deal is just the beginning. The real challenge? Turning that signature into value at speed. And...

As 2025 advances, the M&A landscape is becoming sharper, leaner, and more demanding. High-multiple stories backed by thin logic and vague...

The M&A world isn’t quieting down. It’s getting sharper. In 2025, it’s not about more deals. It’s about smarter ones. The first quarter...